Compare FDC LTD. with Cadila Healthcare - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

FDC LTD. vs CADILA HEALTHCARE - Comparison Results

CADILA HEALTHCARE 
   Change

Cadila Healthcare is one of the leading players in the Indian pharma market having a presence in both the domestic and international markets. In the international markets, the company had adopted the strategy of competing directly in the generics mar... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    FDC LTD. CADILA HEALTHCARE FDC LTD./
CADILA HEALTHCARE
 
P/E (TTM) x 16.2 14.0 115.2% View Chart
P/BV x 2.2 2.7 79.9% View Chart
Dividend Yield % 0.0 1.5 -  

Financials

 FDC LTD.   CADILA HEALTHCARE
EQUITY SHARE DATA
    FDC LTD.
Mar-18
CADILA HEALTHCARE
Mar-18
FDC LTD./
CADILA HEALTHCARE
5-Yr Chart
Click to enlarge
High Rs319558 57.2%   
Low Rs164362 45.4%   
Sales per share (Unadj.) Rs61.6116.3 53.0%  
Earnings per share (Unadj.) Rs9.917.9 55.7%  
Cash flow per share (Unadj.) Rs12.023.1 51.7%  
Dividends per share (Unadj.) Rs03.50 0.0%  
Dividend yield (eoy) %00.8 0.0%  
Book value per share (Unadj.) Rs73.285.4 85.7%  
Shares outstanding (eoy) m174.401,023.74 17.0%   
Bonus/Rights/Conversions BB--  
Price / Sales ratio x3.94.0 99.1%   
Avg P/E ratio x24.325.7 94.3%  
P/CF ratio (eoy) x20.219.9 101.6%  
Price / Book Value ratio x3.35.4 61.3%  
Dividend payout %019.6 0.0%   
Avg Mkt Cap Rs m42,118470,664 8.9%   
No. of employees `0005.511.8 46.8%   
Total wages/salary Rs m2,16718,545 11.7%   
Avg. sales/employee Rs Th1,943.710,072.7 19.3%   
Avg. wages/employee Rs Th391.71,569.1 25.0%   
Avg. net profit/employee Rs Th313.71,547.7 20.3%   
INCOME DATA
Net Sales Rs m10,751119,049 9.0%  
Other income Rs m5101,132 45.0%   
Total revenues Rs m11,260120,181 9.4%   
Gross profit Rs m2,26728,475 8.0%  
Depreciation Rs m3515,388 6.5%   
Interest Rs m14911 1.5%   
Profit before tax Rs m2,41123,308 10.3%   
Minority Interest Rs m-5628 -0.8%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m6715,644 11.9%   
Profit after tax Rs m1,73518,292 9.5%  
Gross profit margin %21.123.9 88.2%  
Effective tax rate %27.824.2 115.0%   
Net profit margin %16.115.4 105.0%  
BALANCE SHEET DATA
Current assets Rs m7,21382,005 8.8%   
Current liabilities Rs m2,10460,720 3.5%   
Net working cap to sales %47.517.9 265.8%  
Current ratio x3.41.4 253.9%  
Inventory Days Days5473 74.5%  
Debtors Days Days2898 28.2%  
Net fixed assets Rs m6,86583,703 8.2%   
Share capital Rs m1751,024 17.1%   
"Free" reserves Rs m12,58686,421 14.6%   
Net worth Rs m12,76187,445 14.6%   
Long term debt Rs m625,551 0.0%   
Total assets Rs m15,041180,653 8.3%  
Interest coverage x173.226.6 651.6%   
Debt to equity ratio x00.3 0.2%  
Sales to assets ratio x0.70.7 108.5%   
Return on assets %11.610.6 109.4%  
Return on equity %13.620.9 65.0%  
Return on capital %19.022.0 86.2%  
Exports to sales %12.30-   
Imports to sales %00-   
Exports (fob) Rs m1,327NA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m1,88942,683 4.4%   
Fx outflow Rs m011,242 0.0%   
Net fx Rs m1,88931,441 6.0%   
CASH FLOW
From Operations Rs m1,4989,193 16.3%  
From Investments Rs m201-9,737 -2.1%  
From Financial Activity Rs m-1,694515 -329.0%  
Net Cashflow Rs m10-29 -35.5%  

Share Holding

Indian Promoters % 68.9 74.8 92.1%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 4.7 8.3 56.6%  
FIIs % 7.5 5.9 127.1%  
ADR/GDR % 0.0 0.0 -  
Free float % 19.0 11.0 172.7%  
Shareholders   23,730 44,069 53.8%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare FDC LTD. With:   BIOCON   WOCKHARDT  AUROBINDO PHARMA  PLETHICO PHARMA  GLENMARK PHARMA  

Compare FDC LTD. With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 292 Points Higher; Automobile and Metal Stocks Witness Buying(Closing)

After opening the day marginally higher, Indian share markets witnessed buying interest throughout the day and ended on a strong note.

Related Views on News

CADILA HEALTHCARE Announces Quarterly Results (1QFY20); Net Profit Down 28.9% (Quarterly Result Update)

Aug 13, 2019 | Updated on Aug 13, 2019

For the quarter ended June 2019, CADILA HEALTHCARE has posted a net profit of Rs 3 bn (down 28.9% YoY). Sales on the other hand came in at Rs 35 bn (up 20.8% YoY). Read on for a complete analysis of CADILA HEALTHCARE's quarterly results.

FDC LTD. Announces Quarterly Results (1QFY20); Net Profit Up 2.4% (Quarterly Result Update)

Aug 6, 2019 | Updated on Aug 6, 2019

For the quarter ended June 2019, FDC LTD. has posted a net profit of Rs 523 m (up 2.4% YoY). Sales on the other hand came in at Rs 3 bn (up 17.9% YoY). Read on for a complete analysis of FDC LTD.'s quarterly results.

FDC LTD. Announces Quarterly Results (4QFY19); Net Profit Up 6.8% (Quarterly Result Update)

May 30, 2019 | Updated on May 30, 2019

For the quarter ended March 2019, FDC LTD. has posted a net profit of Rs 337 m (up 6.8% YoY). Sales on the other hand came in at Rs 3 bn (down 0.6% YoY). Read on for a complete analysis of FDC LTD.'s quarterly results.

CADILA HEALTHCARE Announces Quarterly Results (4QFY19); Net Profit Down 21.0% (Quarterly Result Update)

May 30, 2019 | Updated on May 30, 2019

For the quarter ended March 2019, CADILA HEALTHCARE has posted a net profit of Rs 5 bn (down 21.0% YoY). Sales on the other hand came in at Rs 37 bn (up 14.8% YoY). Read on for a complete analysis of CADILA HEALTHCARE's quarterly results.

FDC LTD. 2017-18 Annual Report Analysis (Annual Result Update)

Mar 28, 2019 | Updated on Mar 28, 2019

Here's an analysis of the annual report of FDC LTD. for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of FDC LTD.. Also includes updates on the valuation of FDC LTD..

More Views on News

Most Popular

My 3 Best Small-cap Stocks to Get Rich in this Market Rebound(Profit Hunter)

Oct 14, 2019

This is once in a decade opportunity to make a killing from smallcap rebound.

Finally, Is the Share Price of Yes Bank Ready for a Rebound?(The 5 Minute Wrapup)

Oct 7, 2019

Here's what every individual investor must know about Yes Bank...

Rebound Riches Could be Yours With These Stocks(Profit Hunter)

Oct 4, 2019

The secret to multibagger is not big businesses, but great managements... Here's how to find them to make the most of once in a decade rebound opportunity.

The One Stock I Like in this Market(The 5 Minute Wrapup)

Oct 10, 2019

There are rare periods in markets when you get good quality stocks at attractive valuations. Is this one such period?

5 Smart Money Stocks to Profit from the Market Rebound(The 5 Minute Wrapup)

Oct 11, 2019

Now is the time to put money in these 5 stocks to take advantage of the recovery in the economy and the markets.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

FDC LTD. SHARE PRICE


Oct 15, 2019 03:37 PM

TRACK FDC LTD.

  • Track your investment in FDC LTD. with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

COMPARE FDC LTD. WITH

MARKET STATS